Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Mar;33(2):436-44.
doi: 10.1016/j.cct.2011.11.002. Epub 2011 Nov 12.

Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community - a potential conduit to improved HIV treatment outcomes

Ali Shabahang Saber-Tehrani  1 , Sandra A Springer, Jingjun Qiu, Maua Herme, Jeffrey Wickersham, Frederick L Altice
Affiliations
Randomized Controlled Trial

Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community - a potential conduit to improved HIV treatment outcomes

Ali Shabahang Saber-Tehrani et al. Contemp Clin Trials. 2012 Mar.

Abstract

Background: HIV-infected prisoners experience poor HIV treatment outcomes post-release. Directly administered antiretroviral therapy (DAART) is a CDC-designated, evidence-based adherence intervention for drug users, yet untested among released prisoners.

Methods: Sentenced HIV-infected prisoners on antiretroviral therapy (ART) and returning to New Haven or Hartford, Connecticut were recruited and randomized 2:1 to a prospective controlled trial (RCT) of 6 months of DAART versus self-administered therapy (SAT); all subjects received case management services. Subjects meeting DSM-IV criteria for opioid dependence were offered immediate medication-assisted treatment. Trained outreach workers provided DAART once-daily, seven days per week, including behavioral skills training during the last intervention month. Both study groups were assessed for 6 months after the intervention period. Assessments occurred within 90 days pre-release (baseline), day of release, and then monthly for 12 months. Viral load (VL) and CD4 testing was conducted baseline and quarterly; genotypic resistance testing was conducted at baseline, 6 and 12 months. The primary outcome was pre-defined as viral suppression (VL<400 copies/mL) at 6 months.

Results: Between 2004 and 2009, 279 participants were screened, of which 202 met eligibility criteria and 154 were ultimately enrolled in the study; 103 subjects were randomized to DAART and 51 to SAT. Subjects were mostly male (81.2%), people of color (87.0%), had an alcohol use disorder (39.7%), had underlying depression (54.2%), were virally suppressed (78.8%) and had a mean CD4=390.7 cells/mL.

Conclusions: Outcomes from this RCT will contribute greatly to HIV treatment outcomes after release from prison, a period associated with adverse HIV and other medical consequences.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of study recruitment, enrollment and completion. DAART: Directly Administered Antiretroviral Therapy; SAT: Self Administered Therapy; ART: antiretroviral therapy; Change in status: sentence modification or prolonged by new charges
See this image and copyright information in PMC

References

    1. Glaze LE. Bureau of Justice Statistics. U.S. Department of Justice; Washington, D.C.: 2010. Correctional Populations in the United States, 2009.
    1. Spaulding AC, Seals RM, Page MJ, Brzozowski AK, Rhodes W, Hammett TM. HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS One. 2009;4:e7558. - PMC - PubMed
    1. Maruschak LM. Bureau of Justice Statistics. U.S. Department of Justice; Washington: 2009. HIV in Prisons, 2007-08.
    1. Satcher Johnson A, Hu X, Hughes D, Campsmith M, Hall I, Prejean J, et al. The HIV/AIDS Surveillance Report. The HIV/AIDS Surveillance Report. Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services; Atlanta: 2007.
    1. Mumola C. Substance abuse and treatment of state and federal prisoners, 1997. Bureau of Justice Statistics, US Department of Justice, Office of Justice Programs; Washington, DC: 1999.

Publication types

Substances